Australian children under the age of two are at risk of contracting pneumococcal disease as the country battles the worst outbreak in 20 years. The Immunisation Foundation of Australia warned there could be a deadly jump in cases in 2025 if new vaccines targeting more deadly strains of pneumococcal failed to be fast-tracked by the federal government. Six-month-old Mabel Goya …
Children under five years of age, especially those aged two years or under, face a high risk of pneumococcal disease, which is caused by infection of a bacteria -- Streptococcus pneumoniae, also known as pneumococcus. This bacterial infection can lead to a range of disease conditions, including pneumonia, meningitis, or blood infections, collectively known as Invasive Pneumococcal Disease. It helps …
For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. If the recommendation is accepted by the Centers for …
Hyderabad: Yashoda Hospital in collaboration with Pfizer India, has launched a Centre of Excellence for adult vaccination in Secunderabad. The CoE, established at Yashoda Hospital, aims to increase the adoption of adult vaccination by creating an end-to-end ecosystem within the hospital to protect patients against vaccine-preventable diseases. The session included insights into Yashoda's vision for the Adult Vaccination Center of …
Serum Institute of India has already produced around 50 million dosages of the Oxford-AstraZeneca COVID-19 vaccine ''Covishield'' and plans to scale it up to 100 million by March next year even as it awaits approval for emergency use authorisation, a top company official said on Monday. The company, which has launched the country’s first indigenously developed pneumococcal vaccine – PNEUMOSIL- …
